Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:04 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes
NCT01804777 · University of New Mexico · EARLY_PHASE1 · terminated · last registry update 2018-05-11 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Currently closed for data analysis.” | – | Registry record, University of New Mexico |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against SCNN1A within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2019-04-25Phase 3 first posted: Hospital de Clinicas de Porto Alegre, Chlorthalidone 25 mg + Hydrochlorothiazide 50 mg (NCT03928145)
- 2019-02-12Phase 3 first posted: University of Missouri-Columbia, Placebo - Cap + Amiloride Pill (NCT03837626)
- 2018-08-31Results posted on the registry: GlaxoSmithKline, GSK3542503 (HCTZ 50mg/Amiloride HCl 5mg tablets) + Moduretic (HCTZ 50mg/Amiloride HCl 5mg tablets) (NCT03031496)
- 2018-07-20Results posted on the registry: State University of New York - Upstate Medical University, amiloride (NCT01733680)
- 2018-07-20Also stopped (terminated): State University of New York - Upstate Medical University, amiloride (NCT01733680)
- 2018-02-12Results posted on the registry: University of Colorado, Denver, sildenafil + calcitonin (NCT00478335)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision